Article
Alcon's Cary Rayment honored as a 'catalyst' for glaucoma work
Cary Rayment, who was honored Jan. 23 by the Glaucoma Research Foundation (GRF) with the 2008 GRF Catalyst Award, is leading his company's strategic plan to spend more than $3.5 billion on research over the next 5 years.
Related Videos
Related Content
Published: October 12th 2024 | Updated: October 11th 2024
First patient dosed at the Tokyo Medical Center by Belite Bio in Phase 2/3 DRAGON II clinical trial
